Airbus SE
Explore by topic
5-year stock timeline
2021 — FY2021: recovery & strong results
Airbus delivered 611 commercial aircraft in 2021 with FY2021 revenues of €52.1bn, adjusted EBIT of €4.9bn, and net income of €4.213bn; a €1.50 dividend was proposed. [19], [13], [39]
The market shifted from pandemic anxiety to a recovery narrative—demand for the A320 family and A220 returned, positioning Airbus as emerging from the trough. [39], [13]
The stock entered a post-COVID recovery uptrend.
Feb–Mar 2022 — Russia invasion; suspension of services to Russian operators
Following Russia's invasion of Ukraine, Airbus suspended deliveries, technical support and spare-parts supply to Russian carriers. Two A350-900s recorded as sold to Aeroflot could not be transferred and were removed from counts. [3], [12], [1]
Investor focus shifted to geopolitical and operational risk, with immediate uncertainty around leased assets in Russia and secondary supply-chain impacts. [3], [6]
The stock experienced increased volatility and drawdown episodes.
2022 (H1 & FY) — supply-chain bottlenecks surface; demand remains strong
H1 2022 saw 297 deliveries with weaker interim profitability (net income €1.901bn). FY 2022 delivered 661 aircraft with 1,078 gross new orders and an elevated backlog. Management warned of broad industrial hurdles and supplier constraints. [30], [1], [37]
The market narrative shifted to "demand intact, execution constrained"—the backlog validated long-term growth, but supplier, engine and aerostructure constraints became the dominant near-term concern. [1], [37]
The stock traded in a range with periodic drawdowns as execution risk re-priced.
2023 — recordable deliveries and sustained order momentum
Airbus delivered 735 commercial aircraft in 2023, including 571 A320-family and 68 A220s, with strong orders and a high backlog. [2], [5]
Sentiment improved as deliveries climbed versus 2022 and demand/replacement cycles remained visible; the narrative reverted toward growth and ramp-up where supply allowed. [5], [2]
The stock rallied in an uptrend as operational momentum resumed.
Feb 2024 — optimistic 2024 guidance (early year)
Management publicly targeted roughly 800 commercial aircraft deliveries for 2024 and reiterated ramp ambitions for the A320 Family. [50]
Market optimism positioned Airbus to take share amid Boeing headwinds and monetize persistent demand. [50]
The stock continued its 2023 uptrend with optimism priced in.
24 June 2024 — guidance update: delivery cut, Space charge, ramp delayed
Airbus announced charges of approximately €0.9bn on certain Space programmes, cut 2024 delivery guidance to approximately 770 aircraft (from approximately 800), and pushed the 75 A320-family/month ramp-up to 2027. Specific supply-chain issues were identified in engines, aerostructures and cabin equipment. [47], [46]
Investor perception flipped to execution skepticism—demand remained strong but near-term earnings, cash flow and programme execution were downgraded. Transparency on Space charges reduced uncertainty but revealed program risk. [47], [46]
The stock experienced a sharp drawdown and single-day sell-off with elevated volatility; shares fell approximately 9–10% on the update. [42], [49]
FY2024 results & 2025 guidance (Feb 2025)
Airbus reported FY2024 results described as "a decent year in a challenging environment" and set guidance for 2025, targeting approximately 820 commercial aircraft deliveries. [4], [53]
Markets moved from panic toward cautious recovery as management provided detail on charges and maintained ramp ambitions; sentiment became constructive but guarded on execution. [4], [53]
The stock recovered into consolidation as volatility moderated.
Early 2026 (Feb 2026) — aiming for record 2026 deliveries but weak start
Airbus publicly aimed for record deliveries in 2026 but admitted January–February deliveries were "quite low" and that early-year challenges were negatively impacting guidance and ramp expectations. [9]
The demand narrative remained intact but execution risk remained the primary driver of short-term valuation, with markets watching monthly delivery flow closely. [9]
The stock traded in a volatile range with rally attempts met by pullbacks around delivery news.
11 July 2026 — Market snapshot: share price 197.12
The share price stands at 197.12. [2], [47], [53]
The price reflects a balance of robust long-term backlog and demand against residual execution and supply-chain risk stemming from the 2024 charge and ramp delays—investors reward volume recovery but maintain an execution discount.
The stock consolidates after a volatile recovery with mixed momentum around the current level.
Key risks and downside factors
Airbus operates across three distinct competitive landscapes. In commercial aviation, Boeing remains its primary adversary, though regional and business-jet markets pit it against Embraer and Textron, with engine and avionics suppliers like Safran, Rolls-Royce, and Raytheon Technologies as secondary competitors. Defense and space operations bring Airbus into direct competition with major primes including Lockheed Martin, Northrop Grumman, BAE Systems, Leonardo, and Thales. The company's risk profile reflects structural vulnerabilities. Airline demand cycles through predictable booms and busts. Program execution remains perpetually consequential—cost overruns and delays cascade through the entire business. Supply-chain concentration creates single points of failure across critical components. Regulatory environments, trade policy, and geopolitical friction can shift overnight, constraining both operations and market access. Most pressingly, state-backed competitors like COMAC and AVIC are no longer distant threats; they're consolidating capability and market share with resources that ignore traditional competitive discipline.
- Cyclical swings in commercial demand coupled with airline order deferrals and cancellations can rapidly erode delivery schedules, revenue, and backlog depth.
- Supply-chain concentration across engines, composites, and avionics has created bottlenecks that ripple through production schedules, inflate costs, and trigger contractual penalties when timelines slip.
- Execution and R&D costs tied to new model launches carry real risk—ramp-up delays, certification hurdles, and the capital intensity of getting these things to market can compress margins faster than expected.
- Regulatory, trade, and geopolitical headwinds—export controls, sanctions, WTO disputes over subsidies, and shifts in defense procurement—combine with intensifying competition from state-backed manufacturers to compress margins.
Competitive landscape
Airbus operates across three distinct segments: commercial airliners, helicopters, and defence and space systems. Boeing remains its primary competitor in commercial aviation, while its defence and avionics business faces competition from Lockheed Martin, Northrop Grumman, Raytheon Technologies, BAE, Leonardo, Thales, Safran and Rolls‑Royce. The company's economics are shaped by large, capital-intensive programs with extended delivery timelines and dependence on an intricate global supply network. Material risks stem from cyclical airline demand, fierce competitive and pricing dynamics, supplier execution and production scaling challenges, plus regulatory, certification and geopolitical exposure.
| Company | Ticker |
|---|---|
| The Boeing Company | BA.NYSE |
| Lockheed Martin Corporation | LMT.NYSE |
| Northrop Grumman Corporation | NOC.NYSE |
| Raytheon Technologies Corporation | RTX.NYSE |
| Safran SA | SAF.PA |
| Leonardo S.p.A. | LDO.MI |
Private competitors
- COMAC (Commercial Aircraft Corporation of China)
- Mitsubishi Aircraft Corporation
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of Airbus SE
Relative Performance vs Benchmarks
| Period | Airbus SE | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +5.57% | +5.55% | +4.71% |
| 3M | +11.04% | +10.18% | +4.48% |
| 6M | -8.30% | -6.79% | -18.01% |
| 1Y | +10.00% | +6.23% | -12.26% |
| 3Y | +55.31% | +0.25% | -18.48% |
| 5Y | +92.74% | +32.41% | +5.50% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 30.8 | 2.1 | 5.9 | 26.1 |
| 1Y ago | 29.1 | 2.0 | 6.2 | 23.2 |
| 3Y ago | 27.1 | 1.7 | 6.9 | 15.8 |
| 5Y ago | 28.8 | 1.6 | 9.4 | 9.7 |
Frequently Asked Questions
Where is the Airbus SE stock traded?
What does Airbus SE do?
What are the key metrics for AIR.XETRA?
How has Airbus SE's stock price performed?
How is AIR.XETRA valued?
Does AIR.XETRA pay dividends?
What are the key risks when investing in AIR.XETRA?
- Cyclical swings in commercial demand coupled with airline order deferrals and cancellations can rapidly erode delivery schedules, revenue, and backlog depth.
- Supply-chain concentration across engines, composites, and avionics has created bottlenecks that ripple through production schedules, inflate costs, and trigger contractual penalties when timelines slip.
- Execution and R&D costs tied to new model launches carry real risk—ramp-up delays, certification hurdles, and the capital intensity of getting these things to market can compress margins faster than expected.
- Regulatory, trade, and geopolitical headwinds—export controls, sanctions, WTO disputes over subsidies, and shifts in defense procurement—combine with intensifying competition from state-backed manufacturers to compress margins.
Who are the main competitors of Airbus SE?
- The Boeing Company (BA.NYSE)
- Lockheed Martin Corporation (LMT.NYSE)
- Northrop Grumman Corporation (NOC.NYSE)
- Raytheon Technologies Corporation (RTX.NYSE)
- Safran SA (SAF.PA)
- Leonardo S.p.A. (LDO.MI)
When does Airbus SE report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 3.20 EUR | 1.81% | 1.79% |
| 2025 | 3.00 EUR | 2.20% | |
| 2024 | 2.80 EUR | 1.71% | |
| 2023 | 1.80 EUR | 1.41% | |
| 2022 | 1.50 EUR | 1.42% | |
| 2020 | 1.80 EUR | 3.17% | |
| 2019 | 1.65 EUR | 1.39% | |
| 2018 | 1.50 EUR | 1.64% | |
| 2017 | 1.35 EUR | 1.89% | |
| 2016 | 1.30 EUR | 2.38% | |
| 2015 | 1.20 EUR | 1.93% | |
| 2014 | 0.75 EUR | 1.41% | |
| 2013 | 0.60 EUR | 1.35% | |
| 2012 | 0.45 EUR | 1.72% | |
| 2012 | 0.39 EUR | 1.45% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 73.42B | 69.23B | 65.45B | 58.76B | 52.15B |
| Operating income (EBIT) | 5.24B | 4.80B | 4.27B | 4.74B | 4.83B |
| Net income | 5.22B | 4.23B | 3.79B | 4.25B | 4.21B |
| Free cash flow | 4.42B | 3.93B | 3.35B | 3.82B | 2.79B |
| Total assets | 134.94B | 129.21B | 118.87B | 115.94B | 107.05B |
| Equity | 26.10B | 19.61B | 17.70B | 12.95B | 9.47B |
| Net debt | 2.17B | -3.73B | -5.15B | -4.84B | -1.11B |
PWP Leeway UG (haftungsbeschränkt)
